Skip to main content
Premium Trial:

Request an Annual Quote

Galectin-3 Included as Biomarker for Heart Failure in ACCF/AHA 2013 Guidelines

Premium

BG Medicine said this week that the 2013 American College of Cardiology Foundation and the American Heart Association Guideline for the Management of Heart Failure has for the first time recognized the role of galectin-3 testing.

This recognition could help drive clinical adoption of the company's BGM-Galectin-3 heart failure diagnostic.

In the guidelines, Galectin-3 testing has been assigned a Level of Evidence of "A", multiple populations evaluated, and a Class of Recommendation corresponding to "May Be Considered" for the purpose of additive risk stratification of acute heart failure patients; and a Level of Evidence of "B", limited populations evaluated, and a Class of Recommendation of "May Be Considered" for risk stratification of ambulatory heart failure patients.

"We believe that the inclusion of galectin-3 in the updated ACCF/AHA Guideline is an important recognition of the potential significance of galectin-3 in the evaluation and management of patients with heart failure," BG Medicine CEO Paul Sohmer said in a statement.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.